• Education
  • |
  • Points
  • Get the app
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home Find Drugs Pill Identifier Find Drug Company Diseases Medical News & Updates
Other Services
MIMS Education MIMS Points Download App
Country
  • a globesingapore
  • a globemalaysia
  • a globeindonesia
  • a globethailand
  • a globephilippines
  • a globevietnam
  • a globeindia
  • a globeaustralia
  • a globekorea
  • a globenew zealand
The MIMS logo.
Molecular structure pattern
  1. Home icon
  2. Diseases
  3. Attention-Deficit/Hyperactivity Disorder
    • Diseases
    • Attention-Deficit/Hyperactivity Disorder
  4. Follow Up

Attention-Deficit/Hyperactivity Disorder Follow Up

Last updated: 18 May 2026
Reviewed by
PAGINATION TESTMIMS Psychiatry Honorary Editorial Advisory Board
Follow Up
Monitoring
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyPathophysiologyRisk Factors
Clinical PresentationHistoryPhysical ExaminationDiagnosis or Diagnostic Criteria
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacological
Monitoring
Alpha-Adrenergic AgonistsSelective Norepinephrine Reuptake InhibitorStimulants*Supplements & Adjuvant TherapyDisclaimerRelated MIMS Drugs
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyPathophysiologyRisk Factors
Clinical PresentationHistoryPhysical ExaminationDiagnosis or Diagnostic Criteria
Differential Diagnosis
EvaluationPrinciples of TherapyPharmacological therapyNonpharmacological
Monitoring
Alpha-Adrenergic AgonistsSelective Norepinephrine Reuptake InhibitorStimulants*Supplements & Adjuvant TherapyDisclaimerRelated MIMS Drugs

Monitoring

Attention Deficit Hyperactivity Disorder_Follow UpAttention Deficit Hyperactivity Disorder_Follow Up




Initially, monitor on a monthly basis until a consistent optimal response is noted; then every 3 months in the first year of treatment. Subsequent follow-up will depend on the patient's response, adherence to the treatment strategy, and presence of associated conditions. Monitoring is recommended at least twice a year. Monitor treatment outcomes and adverse effects (cardiovascular effects, development of tics or seizures, sexual dysfunction, changes in sleep pattern, worsening behavior, stimulant misuse, and diversion) by gathering information from parents, teachers, and the child. Monitor core symptoms using DSM-5-TR-based attention-deficit/hyperactivity disorder (ADHD) rating scales (eg Vanderbilt ADHD follow-up scales). Re-evaluate the patient when the treatment and management plan do not meet desired outcomes. Reassess the patient at school-leaving age to check for continuity of care into adulthood.

 

The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty release/v3.16.0_3176.1
Copyright © 2026 MIMS Pte Ltd. All rights reserved. UAT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.